Together with the observed differential growth in the WT animals, these results showed that an increased susceptibility to RIPK1-dependent cell death (conferred by SHARPIN deficiency) does not result in spontaneous tumor cell death, but rather sensitizes to T cell–mediated tumor destruction. This evidence concerns the gene RIPK1 and neoplasm.